SIROLIMUS — all Canadian products
8 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SIROLIMUS, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02373394 | GD-SIROLIMUS | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | Oral | SIROLIMUS 1 MG | Approved | |
| 02373386 | GD-SIROLIMUS | GENMED A DIVISION OF PFIZER CANADA ULC | Solution | Oral | SIROLIMUS 1 MG | Approved | |
| 02243237 | RAPAMUNE | PFIZER CANADA ULC | Solution | Oral | SIROLIMUS 1 MG | Marketed | |
| 02247111 | RAPAMUNE | PFIZER CANADA ULC | Tablet | Oral | SIROLIMUS 1 MG | Marketed | |
| 02373408 | GD-SIROLIMUS | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | Oral | SIROLIMUS 2 MG | Cancelled Pre Market | |
| 02373416 | GD-SIROLIMUS | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | Oral | SIROLIMUS 5 MG | Cancelled Pre Market | |
| 02270684 | RAPAMUNE | PFIZER CANADA ULC | Tablet | Oral | SIROLIMUS 5 MG | Cancelled Pre Market | |
| 02270617 | RAPAMUNE | PFIZER CANADA ULC | Tablet | Oral | SIROLIMUS 2 MG | Cancelled Pre Market |
Browse other molecules: